Report: Re-use of Mini-Sentinel Data Following Rapid Assessments of Potential...
This report summarizes the deliberations of the Mini-Sentinel Data Re-use Committee with regard to re-using data for subsequent assessments of potential safety signals following rapid assessments of...
View ArticleModular Program 7: Documentation and Code v2.0
Modular Program #7 reports the most frequent (top XX) diagnosis, procedure, and/or outpatient pharmacy dispensing codes before and after an index medical product exposure or event of interest. Example:...
View ArticleModular Program 6: Documentation and Code v2.0
Modular Program #6 characterizes the occurrence of events of interest (defined using the MSCDM procedure or diagnosis tables), and examines the frequency and duration of subsequent treatment with...
View ArticleModular Program 5: Documentation and Code v2.0
Modular Program #5 characterizes background rates for any condition or exposure defined using the MSCDM outpatient pharmacy dispensing, diagnosis and procedure tables. Example: the proportion of...
View ArticleModular Program 4: Documentation and Code v2.0
Modular Program #4 characterizes the use of a primary exposure of interest and examines concomitant use of a secondary exposure. Metrics reported include concomitance intensity (of primary users,...
View ArticleModular Program 3: Documentation and Code v2.0
Modular Program #3 characterizes episodes of incident\prevalent use of specified medical product exposures (defined using the MSCDM outpatient pharmacy dispensing and procedure tables), and examines...
View ArticleModular Program 2: Documentation and Code v2.0
Modular Program #2 characterizes the incident and prevalent use of specified medical products or procedures defined using the MSCDM outpatient pharmacy dispensing and procedure tables among individuals...
View ArticleModular Program 1: Documentation and Code v2.0
Mini-Sentinel modular programs (MPs) are SAS programs designed to run against the Mini-Sentinel Common Data Model (MSCDM). They allow rapid implementation of standard queries across the Mini-Sentinel...
View ArticleSummary Table Report: Injection Natalizumab Procedures
Summary table assessment of the use of Injection Natalizumab (HCPCS code J2323). Results were generated using the Mini-Sentinel Distributed Query Tool and the HCPCS Summary Table. Summary tables are...
View ArticleSummary Table Report: Injection Ustekinumab and Injection Dronedarone Procedures
Summary table assessment of the occurrence of procedure codes for “Injection Ustekinumab 1MG” (HCPCS Code C9261), and “Injection Denosumab 1MG” (HCPCS Code C9272). Results were generated using the...
View ArticleSummary Table Report: Natalizumab and Efalizumab Use
Summary table assessment of the use of Natalizumab and Efalizumab. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled...
View ArticleSummary Table Report: Golimumab, Ustekinumab, and Dronedarone Hydrochloride...
Summary table assessment of the use of Golimumab, Ustekinumab, and Dronedarone Hydrochloride by year. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary...
View ArticleSummary Table Report: Golimumab, ustekinumab, and dronedarone hydrochloride...
Summary table assessment of the use of Golimumab, Ustekinumab, and Dronedarone Hydrochloride by quarter. Results were generated using the Mini-Sentinel Distributed Query Tool and Dispensing Summary...
View ArticleSummary Table Report: Occurrence of Selected Generic Drugs 5
Summary table assessment of the use of Alosetron hydrochloride (HCL), Ambrisentan, Bosentan, Buprenorphine HCL, Buprenorphine HCL /Nalonxone HCL, Eltrombopag Olamine, Fentanyl, Hydromorphone HCL,...
View ArticleSummary Table Report: Occurrence of Selected Generic Drugs 4
Summary table assessment of the use of Modafinil, Meloxicam, Piroxicam, Sulfamethoxazole, and Sulfamethoxazole/Trimethoprim. Results were generated using the Mini-Sentinel Distributed Query Tool and...
View ArticleSummary Table Report: Occurrence of Selected Generic Drugs 3
Summary table assessment of the use of Alosetron Hydrochloride (HCL), Ambrisentan, Bosentan, Buprenorphine HCL, Buprenorphine HCL/Naloxone HCL, Fentanyl, Hydromorphone HCL, Isotretinoin, Lenalidomide,...
View ArticleModular Program Report: Clopidogrel and Prasugrel Use
Modular program-based one-time assessment of the use of clopidogrel and prasugrel in the Mini-Sentinel Distributed Database. Modular programs are adaptable standardized programs. Queries were executed...
View ArticleModular Program Report: Selgiline Use
Modular program-based one-time assessment of the use of selgiline in the Mini-Sentinel Distributed Database. Modular programs are adaptable standardized programs. Queries were executed in March-April...
View ArticleModular Program Report: Duloxetine, Milnacipran, and Pregabalin Use 2
Modular program-based one-time assessment of the use of duloxetine, milnacipran, and pregabalin among enrollees with a pre-existing diagnosis of myalgia or myositis in the Mini-Sentinel Distributed...
View ArticleModular Program Report: Buproprion and Naltrexone Use 2
Modular program-based one-time assessment of the use of bupropion and naltrexone in the Mini-Sentinel Distributed Database. Modular programs are adaptable standardized programs. Queries were executed...
View Article
